Research Use Only. Not for human consumption, medical use, diagnosis, or treatment. By purchasing, you agree to laboratory use guidelines.
RETAKLIK 2.0 (Retatrutide) 45mg
RETAKLIK 2.0 is a synthetic triple receptor agonist targeting GLP-1, GIP, and glucagon receptor pathways, designed exclusively for in vitro and in vivo laboratory research applications for studying metabolic regulation and receptor signalling in controlled settings. Supplied as 45mg in pre-filled research devices for controlled laboratory and R&D use only. Delivered in sealed format to support formulation assessment, compound stability testing, and delivery system evaluation. All products are for research purposes only. Not for human consumption, medical use, diagnosis, or treatment.
Triple Tested
HPLC & MS verified for consistent potency thresholds.
Priority Post
Discreet Next Day Delivery on all research orders.
Janoshik Analytical Verification
All batches are independently verified. You can cross-reference the batch number with the report library.
View Certificate of Analysis →